Use of high-dose hemodiafiltration improves survival in individuals with kidney failure: NEJM
Written By : Chumbeni
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2023-07-04 05:00 GMT | Update On 2023-07-04 06:12 GMT
Advertisement
Netherlands: Researchers have found in the multinational, randomized, controlled trial involving 1360 kidney failure patients that high-dose hemodiafiltration resulted in a lower risk of death than conventional high-flux haemodialysis. The study is published in The New England Journal of Medicine.
Dr Blankestijn and team conducted the study for at least three months, ensuring that all the patients were eligible for a convection volume of at least 23 litres per session, requiring high-dose hemodiafiltration. Of 1360 patients enrolled, either the high-dose hemodiafiltration group (683 patients) or the high-flux hemodialysis group (677 patients) were randomly assigned.
The key findings of this study are:
- The study revealed that 17.3% of patients in the high-dose hemodiafiltration group experienced death from any cause, compared to 21.9% in the high-flux hemodialysis group.
- The hazard ratio of death from any cause for the hemodiafiltration group versus the hemodialysis group was 0.77 (95% confidence interval, 0.65 to 0.93).
- The median follow-up period was 30 months, during which the hemodiafiltration group achieved a mean convection volume of 25.3 litres per session.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.